Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Overview of attention for article published in BMC Cancer, April 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 108 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,844 followers.

@tomboike @DrRanaMcKay @HimanshuNagarMD @ALLIANCE_org @morr316 @alantanmd @DrScottTagawa @DrSpratticus The Greater LA VA and UCLA group also have a trial that recently completed accrual in De Novo Oligometastatic disease testing local therapy with MDT in t

13 May 2022

Reply Repost Favourite

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease. https://t.co/Vl5318mwDF H/T @NCBI #radonc #PubMed

04 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.